MaxCyte (MXCT) Earnings Analysis
MaxCyte (MXCT) next reports earnings on 2026-08-12, consensus EPS -0.12 USD. Last quarter (2026-03-24) it beat with EPS -0.06 USD vs -0.08 USD est (+25%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -3.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MXCT next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.12 USD |
| Revenue estimate | 0.01B |
MXCT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | -0.06 USD | -0.08 USD | +25% | Beat |
| 2025-11-12 | -0.12 USD | -0.11 USD | -9.1% | Miss |
| 2025-03-11 | -0.1 USD | -0.12 USD | +16.7% | Beat |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
MXCT valuation and analyst view
| Trailing P/E | -3.05 |
|---|---|
| Trailing EPS | -0.36603 USD |
| Price / book | 0.73 |
| Dividend yield | 0.00% |
| Market cap | 0.13B |
| Analyst consensus | Buy (4 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is MaxCyte (MXCT)'s next earnings date?
MaxCyte is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.12 USD and revenue estimate of 0.01B.
Did MXCT beat earnings last quarter?
In its 2026-03-24 report, MXCT posted EPS of -0.06 USD versus a -0.08 USD estimate — a beat of 25%.
What is MXCT's earnings track record?
Over the last 3 reported quarters with consensus data, MXCT beat estimates 2 times (67%).
What is MXCT's current P/E ratio and EPS?
MXCT trades at a trailing P/E of -3.05 on trailing EPS of -0.36602543303660656 USD.
What do analysts rate MXCT?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell).